Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

ClinicalTrials.gov ID: NCT01208233

Public ClinicalTrials.gov record NCT01208233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 8, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and tolerability of PF-03049423 following multiple dose administration to subjects with ischemic stroke. The study will also evaluate the efficacy of PF-03049423, relative to placebo, in subjects with ischemic stroke following 90 days of therapy. The study will also explore the relationship between PF-03049423 concentration and blood pressure.

Study identification

NCT ID
NCT01208233
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
181 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2010 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Dec 2013 (Actual)
Last update posted
Feb 19, 2016

2010 – 2013

United States locations

U.S. sites
32
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Spain Rehabilitation Center Birmingham Alabama 35233 —
The Kirklin Clinic Birmingham Alabama 35233 —
University Hospital Birmingham Alabama 35294-3280 —
Broward Health North Deerfield Beach Florida 33064 —
Neurologic Consultant, P.A. Fort Lauderdale Florida 33308 —
Fawcett Memorial Hospital Port Charlotte Florida 33952 —
Neurostudies, Inc. Port Charlotte Florida 33952 —
Jagdish Sidhpura M.D. Columbus Georgia 31901 —
Jose Canedo, M.D., West Georgia Neurology Columbus Georgia 31904 —
St. Francis Hospital Columbus Georgia 31904 —
Muscogee Manor & Rehabilitation Center Columbus Georgia 31907 —
Medical Research & Health Education Foundation, Inc. Columbus Georgia 31909 —
Parkview Hospital Randallia Fort Wayne Indiana 46805 —
Fort Wayne Neurological Center Fort Wayne Indiana 46845 —
Parkview Regional Medical Center Fort Wayne Indiana 46845 —
Parkview Research Center Fort Wayne Indiana 46845 —
Norwood Nursing Center Huntington Indiana 46750 —
Massachusetts General Hospital/Department of Neurology Boston Massachusetts 02114 —
Spaulding Rehabilitation Hospital Boston Massachusetts 02129 —
Wayne State University Detroit Michigan 48201 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Rehabilitation Institute of St. Louis St Louis Missouri 63110 —
UNC HealthCare Chapel Hill North Carolina 27514 —
UNC Department of Neurology Stroke Division Chapel Hill North Carolina 27599-7025 —
Investigational Drug Services at OU Medical Center Oklahoma City Oklahoma 73104 —
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104 —
OU Medical Center Oklahoma City Oklahoma 73104 —
OU Physicians Building Oklahoma City Oklahoma 73104 —
Penn State Milton South Hershey Medical Center / Penn State College of Medicine Hershey Pennsylvania 17033 —
Penn State Hershey Rehabilitation Hospital Hummelstown Pennsylvania 17036 —
The Methodist Hospital Neurological Institute Houston Texas 77030 —
The Methodist Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01208233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2016 · Synced Oct 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01208233 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →